Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Shanghai OPM Biosciences' low ROE may alarm investors. Yet, ...

Shanghai OPM Biosciences' low ROE may alarm investors. Yet, sharp net income rise, perhaps from management choices or minor payout rate, stands out. High-return reinvestment could be driving its earnings surge.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1699 Views
Comment
Sign in to post a comment